TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Visual Analogue Scale for pain
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Change in movement in the affected fingers and wrist
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response rate using irRECIST
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Progression free survival using RECIST 1.1 and irRECIST
Endpoint domain: Mortality/survival
Primary endpoint: Change in 6-minute Walk Test Distance (6MWD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Body Weight (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Strength in upper and lower limbs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak percentage change from baseline eosinophil count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Rate of Undetected Minimal Residual Disease (U-MRD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: ovarian stimulation safety
Endpoint domain: Adverse events/effects
Primary endpoint: Posture dependence of the VCG-ECG-Transformation matrix
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Surrogate Satisfaction with Patient Care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Implant and prosthetic success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Failure rate of the restrictive DEX regimen
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of Participants Classified as Successes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Verbal Pain Scale Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent Change From Baseline in Glycosylated Hemoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Serum Calcium Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Serum Intact Parathyroid Hormone (iPTH) Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Incidence of solicited and unsolicited adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of subjects with influenza or influenza-like illnesses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: SH-index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Any Adverse Events (AE) and Serious Adverse Events (SAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Mean Change From Baseline in Heart Rate (HR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Retention to the trial at 3-month follow up
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Retention to the trial at 6-month follow up
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of patients with guideline compliant care
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Energy substrate use
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of contacts due to postoperative pain
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with serum and plasma bank creation
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: clinical outcome parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: risk of falling score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ETT hung-up at the laryngeal inlet
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Prevention of anastomotic stomal ulcer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Prevalence of transient preschool wheeze
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Insomnia severity index
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Anti-pneumococcal Vaccine Serotype Antibody Concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Montgomery Asberg Depression Rating Scale for Depression (MADRS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of correct movements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Responder rate at peak effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in duration of constant load exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in aerobic capacity (peak VO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment-Emergent Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Disease stabilization (CR, PR, SD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in levels of Fetuin A in serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in levels of MMP7 in serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with complications
Endpoint domain: Adverse events/effects
Primary endpoint: Change In Coefficient Of Fat Absorption (CFA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Serious adverse drug reactions including major hypoglycaemic events
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in fasting total cholesterol concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Ratio of LDH to the Upper Limit of Normal (ULN)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number and Type of Adverse Events (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Mean Glycemic Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Radiological changes in rachitic lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Substance use behaviors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Consequences of substance use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Antithrombin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Progression of artic dilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency, type, and severity of adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Dose Limiting Toxicities (DLTs) in Cycle 1
Endpoint domain: Adverse events/effects
Primary endpoint: Time to reach cecal base
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of participants with clinical laboratory abnormalities
Endpoint domain: Adverse events/effects
Primary endpoint: Total Nail Clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in symptom burden
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Accuracy of esophageal and anorectal manometric pressure measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perianal skin maceration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Maximally Tolerated Dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Brown adipose tissue volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percent of patients tolerant to study drug
Endpoint domain: Adverse events/effects
Primary endpoint: Success rate of complete regression of atypical endometrial hyperplasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Mediterranean diet adherence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: moderate to vigorous level of physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: stress level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Spontaneous delivery before 34 complete weeks
Endpoint domain: Mortality/survival
Primary endpoint: Reward region activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sickle Cell Crisis Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of surgical wound infection
Endpoint domain: Adverse events/effects
Primary endpoint: Change in parental ratings of child's quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: participant feedback
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: adherence to diet
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum carotenoids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: serum free fatty acids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: obtaining sputum samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in ATEC scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in ABC scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in QoLA-P scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Prediction of glioblastoma true progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Children's Depression Rating Scale - Revised (CDRS-R) Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Time Till Employment in Days
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Tumor contrast-to-noise ratio (CNR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tumor Motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Health services utilization
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Discharge destination
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Alternate Level of Care (ALC) assignment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: National Rehabilitation Reporting System (NRS) assessments
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rehabilitation Patient Group (RPG)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Participants With Grade 3 and 4 Lab Abnormalities
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Grade 3 and 4 Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Endo-peripheral artery tonometry (EndoPAT) index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Psoriasis Area and Severity Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: radiographic interproximal bone level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive test in MMST results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Posterior wall common carotid intima-media thickness (IMT) progression rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: oocyte quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gestational Length
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Cognitive Development
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: NEPSY Memory for faces
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measurement of Salivary Cortisol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Event Related Potentials (ERP) incidental memory task
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Critical closing pressure (Pcritgs) of the upper airway
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Failure free survival at 5 years
Endpoint domain: Mortality/survival
Primary endpoint: Change in Total Bacterial Load on the Exposed Implant Surface
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Cesarian section rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Acceptability of contraceptive options
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in sexual function based on the IIEF-5 score
Endpoint domain: Life impact
Endpoint subdomain: Sexual functioning
Primary endpoint: Post-dialysis Recovery Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Intradialytic Hypotension
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of Dialysis Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety as assessed by measuring immunogenicity
Endpoint domain: Adverse events/effects
Primary endpoint: Area under the plasma concentration vs time curve from time 0 to the last data point (AUC0-tlast)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum drug concentration in plasma (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional severity of arthrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: 5-years survival rate
Endpoint domain: Mortality/survival
Primary endpoint: Cutting surface related complications
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Complete Epithelialization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Objective Response Rate of Intracranial Lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change from baseline respiratory quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change from baseline anxiety and depression symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in prevalence of baseline depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Gastroesophageal reflux disease (GERD) symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Pain during spinal needle insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants With at Least 20 Percent Improvement in PANSS Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in PANSS Total Score at Endpoint
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Abstinence from opioid use
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Generalised Anxiety Disorder-7 (GAD-7)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Progression to multiple sclerosis
Endpoint domain: Mortality/survival
Primary endpoint: Residual Apnea Hypopnea Index (AHI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Advanced glycation end products levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Expression of Cox-2 and PGE2 in the lungs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Suppression of intrapulmonary formation of PGE2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percent Improvement in PtcO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent Improvement in PtcCO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in PEFR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Percentage of Participants With Seroconversion in rLP2086 Specific Serum Bactericidal Assay (SBA) Titer 1 Month After Dose 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of Participants With Seroconversion in rLP2086 Specific SBA Titer 1 Month After Dose 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: mortality of blue-codes
Endpoint domain: Mortality/survival
Primary endpoint: Procedure Duration
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Success of ablation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Seroconverted Subjects for Anti-rotavirus IgA Antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of patients obtaining RO resection
Endpoint domain: Mortality/survival
Primary endpoint: Rate of neurocognitive development
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Sex-specific mortality
Endpoint domain: Mortality/survival
Primary endpoint: Recurrence of abnormal vaginal flora
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AMI and ischemic stroke
Endpoint domain: Mortality/survival
Primary endpoint: Change in peak inspiratory flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in tidal volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in minute ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Total dose of iv fentanyl used during oocyte collection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Korean Version of the Attention-Deficit/Hyperactivity Disorder (ADHD) Rating Scale (K-ARS) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Global Impression - Severity (CGI-S) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Global Impression - Improvement (CGI-I) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Learning Skill Test (LST) Total Score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: tolerance of the patients
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of Positive Toxicology Swabs for Illicit Substances
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment Failures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Asthma Control Days
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percent Predicted FEV1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Severity of depressive episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in SARS-CoV-2 Viral load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Reduction in Severity of COVID-19 Disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 7 day point prevalence biochemically verified abstinence rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CBCL-DP score variation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: KOOS pain sub score
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Dilation Duration of Second Stage of Labor Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Delivery Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Surface EMG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Free Fatty Acid Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Clinical Attachment level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants with post-vaccination titer ≥1:40 or ≥4-fold titer increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Closure of staple line leak
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in number of social behaviors
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Pain assessed with a Visual Analog Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Swelling measured by an scale in mm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mouth Opening measured by an scale in mm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Sexual Risk Behavior
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances